The MORSE Team
Who We Are
MORSE is Canada’s leading market access strategy consultancy, focused on developing comprehensive reimbursement strategies that address our Clients’ needs.
Our team of experts use their unique combination of real-world experience, technical skill, and nuanced understanding of the Canadian payer context to provide honest and practical guidance to our clients on navigating the market’s complexities.
We focus on being our clients’ strategic partners across the product’s life cycle, complementing the technical work done by HTA submission dossier vendors.
Why MORSE?
Unparalleled Expertise & Unique Perspectives
Our consultants have deep experience in various settings, including public drug programs, industry, and consulting agencies
Foundation of Strong Relationships & Trust
We explain complex and challenging issues to clients in an authentic, unbiased, and highly credible manner
Strategic Insights to Guide Access Decisions & Deliverables
We are committed to providing innovative solutions to inform strategic decisions on new product launches, indications, and life-cycle management
Who We Are
In January 2017, Arvind Mani and Sherry O’Quinn established Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. This company was created with a shared focus to create a market access consultancy aimed at developing creative solutions for challenging reimbursement situations.
Both Arvind and Sherry have a passion for understanding and exploring emerging healthcare trends to better advise clients and improve the market access dialogue. MORSE aims to be a leader in this space based not only on the insights it provides but the manner in which these observations are communicated.
The MORSE Approach
RESEARCH
MORSE is well versed in both primary (payers, clinicians, patients) and secondary (market access sources) research methodology.
EXPLORE
The MORSE team has an established track record for exploring topics on the leading edge of market access (biosimilar uptake, public payer PLA negotiation expectations, private payer PLAs).
STRATEGIZE
MORSE’s ability to research and explore emerging areas of interest combined with its team’s broad healthcare expertise are the foundations for helping develop effective strategies for clients.
COMMUNICATE
MORSE possesses the invaluable skill of distilling seemingly complicated elements of the reimbursement environment into understandable and actionable advice for clients.
- Managing Director
- Managing Principal
- Director of Pharmacoeconomics and RWE
- Executive Director
- Senior Consultant
- Senior Consultant
- Senior Consultant, Private Drug Plans
- Market Access & Data Analytics Manager
- Senior Market Access Analyst
- Market Access Analyst
- Market Access Associate
- Market Access Analyst
The MORSE Vision
To be a leader in strategic pharmaceutical reimbursement consulting with a reputation for honesty, integrity, and collaboration.
Our team has been recognized by the market access community for their commitment to excellence and providing meaningful, tangible and practical advice to help our clients navigate the increasingly sophisticated market access landscape.
We Possess
- An understanding of a broad range of therapeutic areas including oncology
- A combined 40+ years working in health care specializing in pharmaceuticals
- Experience across many perspectives: government, consulting, associations, private industry, primary care, not for profit, and charitable organizations
- Expertise in developing strategy for health technology assessment, pricing, and product listing agreement negotiation
